KX-826

· Suzhou Koshine Biomedica, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for KX-826, covering 2023-07-19 to 2024-05-22. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic Alopecia [Phase 2]